# Bristol-Myers Squibb Company (NYSE: BMY), Madison, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/bristol-myers-squibb-company/3734a119-014f-49c6-b518-fc8b1dea7f92

> Inspection records and compliance data for Bristol-Myers Squibb Company in Madison, New Jersey. 17 FDA inspections on record, 4 Form 483s, last inspected June 23, 2026. Publicly traded as NYSE: BMY.

---

## Details

- Name: Bristol-Myers Squibb Company
- FEI Number: 3004991673
- Address Line 1: 5 Giralda Farms
- City: Madison
- State: New Jersey
- Zip Code: 07940
- Country Name: United States
- Address: 5 Giralda Farms, Madison, New Jersey 07940, United States
- Country: United States

## Stock

- Stock ticker: BMY
- Exchange: NYSE
- Share price: $62.37
- Market cap: $127.5B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1327472 - Bristol-Myers Squibb Company - 2026-06-23 — source: FDA, date: June 23, 2026
- [483 - Bristol-Myers Squibb Company - 2025-07-18](https://www.keypedia.com/records/483/bristol-myers-squibb-company/3f16d573-7ac8-419f-9ff4-2b070cead434) — source: FDA, date: July 18, 2025
- [FDA Inspection 1275526 - Bristol-Myers Squibb Company - 2025-07-18](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/e6f01d89-0a13-4fb3-a74e-dfb41429a3bc) — source: FDA, date: July 18, 2025
- FDA Inspection 1275526 - Bristol-Myers Squibb Company - 2025-07-18 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 18, 2025
- [483 - Bristol-Myers Squibb Company - 2024-12-06](https://www.keypedia.com/records/483/bristol-myers-squibb-company/97218ac0-74e3-4a85-83a2-081a9e0504fb) — source: FDA, date: December 6, 2024
- [FDA Inspection 1236864 - Bristol-Myers Squibb Company - 2024-12-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/41559cd5-b35e-471a-8003-1db4082c038a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024
- FDA Inspection 1236864 - Bristol-Myers Squibb Company - 2024-12-06 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2024
- FDA Inspection 1247735 - Bristol-Myers Squibb Company - 2024-09-06 — source: FDA, date: September 6, 2024
- [FDA Inspection 1247735 - Bristol-Myers Squibb Company - 2024-09-06](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/b8ae4944-d185-4142-8468-e00f31678546) — classification: No Action Indicated (NAI), source: FDA, date: September 6, 2024
- FDA Inspection 1228973 - Bristol-Myers Squibb Company - 2024-01-31 — classification: No Action Indicated (NAI), source: FDA, date: January 31, 2024
- [483 - Bristol-Myers Squibb Company - 2023-06-16](https://www.keypedia.com/records/483/bristol-myers-squibb-company/4ea843bb-7d44-433b-b1f8-807afaf7865e) — source: FDA, date: June 16, 2023
- [FDA Inspection 1208871 - Bristol-Myers Squibb Company - 2023-06-16](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/ad863020-b34a-40d2-91ba-237fdca75cc3) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 16, 2023
- [EIR - Bristol-Myers Squibb Company - 2022-03-14](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/d539f239-1103-4fe2-acdf-a6f28938d6e1) — source: FDA, date: March 14, 2022
- [FDA Inspection 1165563 - Bristol-Myers Squibb Company - 2022-03-14](https://www.keypedia.com/records/fda_inspections/bristol-myers-squibb-company/3425021c-e05a-405a-b49d-269fd28c5388) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2022
- [EIR - Bristol-Myers Squibb Company - 2021-02-19](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/7b32696e-62a4-4a27-8f45-4c62ffd707fd) — source: FDA, date: February 19, 2021
- [483 - Bristol-Myers Squibb Company - 2021-02-19](https://www.keypedia.com/records/483/bristol-myers-squibb-company/de025911-4ac0-4553-854c-d1edad23420a) — source: FDA, date: February 19, 2021
- [EIR - Bristol-Myers Squibb Company - 2020-06-03](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/ceb890a7-c101-4a8a-a3c3-8bc64d805436) — source: FDA, date: June 3, 2020
- [EIR - Bristol-Myers Squibb Company - 2018-06-27](https://www.keypedia.com/records/eir/bristol-myers-squibb-company/3e34c869-a4ff-4ba5-8934-942d904b3832) — source: FDA, date: June 27, 2018
- [483 - Bristol-Myers Squibb Company - 2017-01-25](https://www.keypedia.com/records/483/bristol-myers-squibb-company/d9ab1e53-7ce9-4a8c-b38e-01f5e565a0ed) — source: FDA, date: January 25, 2017
- [483 - Bristol-Myers Squibb Company - 2012-07-30](https://www.keypedia.com/records/483/bristol-myers-squibb-company/10c364b5-0a3f-4a9c-9052-a72355ca9483) — source: FDA, date: July 30, 2012

## Related Companies

- [Hospira Zagreb d.o.o.](https://www.keypedia.com/companies/hospira-zagreb-doo/7c1e84f8-a21e-4e90-896a-ac33304219f1)
- [Boehringer Ingelheim Fremont, Inc.](https://www.keypedia.com/companies/boehringer-ingelheim-fremont-inc/3d7d0ca7-27cd-4223-8ade-7193417c9861)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Novartis Pharma Stein AG](https://www.keypedia.com/companies/novartis-pharma-stein-ag/06be1f01-8421-471e-9d38-475fef9a9c5b)
- [Sinopep-Allsino Biopharmaceutical Co., Ltd.](https://www.keypedia.com/companies/sinopep-allsino-biopharmaceutical-co-ltd/f45b83cf-0416-4308-92bf-f7f3212ca356)
- [Fujian Genohope Biotech Ltd.](https://www.keypedia.com/companies/fujian-genohope-biotech-ltd/2383a4ad-4fe8-4b52-b528-9b72885e00a9)
- [Novartis Manufacturing LLC](https://www.keypedia.com/companies/novartis-manufacturing-llc/c4165663-ccb2-4abd-bba3-af6a0bdf462d)
- [Celltrion Inc.](https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b)
- [STgen Bio Co., Ltd.](https://www.keypedia.com/companies/stgen-bio-co-ltd/bf0530c2-b747-4fce-ade6-52850415aac3)
- [Patheon Biologics Australia Pty Ltd](https://www.keypedia.com/companies/patheon-biologics-australia-pty-ltd/ede6b641-a0a7-4b0b-918b-f09c3b1d060b)

## Related Officers

- [Anna Kivile](https://www.keypedia.com/people/anna-kivile/f4cf8dfa-4ab8-4cfe-8101-98f9c1d17c0e)
- [Anna Conley](https://www.keypedia.com/people/anna-conley/c4e548c2-65c1-4225-af38-e93529002757)
- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)
- [issuing_officer](https://www.keypedia.com/people/joseph-h-erdmann/5ca5c109-e4df-4dcb-bc2d-0bb763951f24)
- [issuing_officer](https://www.keypedia.com/people/amalia-c-himaya/36a0063f-06c2-49d9-913b-8673e1707d1e)
